PMID- 20730526 OWN - NLM STAT- MEDLINE DCOM- 20110105 LR - 20191210 IS - 1618-2650 (Electronic) IS - 1618-2642 (Linking) VI - 398 IP - 4 DP - 2010 Oct TI - A rapid and sensitive assay for determining human brain levels of farnesyl-(FPP) and geranylgeranylpyrophosphate (GGPP) and transferase activities using UHPLC-MS/MS. PG - 1801-8 LID - 10.1007/s00216-010-4088-7 [doi] AB - The isoprenoids farnesyl-(FPP) and geranylgeranylpyrophosphate (FPP and GGPP) are two major lipid intermediates in the mevalonate pathway. They participate in post-translational modification of members of the superfamily of small guanosine triphosphatases (GTPases; Ras, Rab, Rac, etc.) via prenylation reactions. Due to the important role of these proteins in a number of cell processes, in particular cell growth, division, and differentiation, investigation of the involvement of isoprenoids in these processes is of great interest. In a previously published report, we described a fully validated assay for the quantitation of the two isoprenoids using a high-performance liquid chromatography (HPLC)-fluorescence detection (FLD) method. The current work expands on the previous method and enhances it greatly by using a much faster state-of-the-art ultrahigh-performance liquid chromatography (UHPLC) technique coupled to tandem mass spectrometry (MS/MS). The method exhibited a linear concentration range of 5-250 ng/mL for FPP and GGPP in human brain tissue; it was shown to be unaffected by ion suppression and provided results almost six times faster than the HPLC-FLD assay. Comparison of UHPLC-MS/MS and HPLC-FLD yielded excellent comparability of the two assays for both isoprenoids. Based on the UHPLC-MS/MS assay, a novel in vitro test system was implemented to study enzyme specificity for distinct amino acid CAAX motifs, which is potentially useful for investigating target interactions of new therapeutics for diseases involving pathological regulation of isoprenoids and/or small GTPases. FAU - Hooff, Gero P AU - Hooff GP AD - Department of Pharmacology, Biocenter Niederursel, University of Frankfurt, Max-von Laue-Str. 9, 60438 Frankfurt, Germany. FAU - Patel, Nina AU - Patel N FAU - Wood, W Gibson AU - Wood WG FAU - Muller, Walter E AU - Muller WE FAU - Eckert, Gunter P AU - Eckert GP FAU - Volmer, Dietrich A AU - Volmer DA LA - eng GR - AG18357/AG/NIA NIH HHS/United States GR - AG23524/AG/NIA NIH HHS/United States GR - Medical Research Council/United Kingdom PT - Evaluation Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20100821 PL - Germany TA - Anal Bioanal Chem JT - Analytical and bioanalytical chemistry JID - 101134327 RN - 0 (Polyisoprenyl Phosphates) RN - 0 (Sesquiterpenes) RN - 79W6B01D07 (farnesyl pyrophosphate) RN - EC 2.5.- (Alkyl and Aryl Transferases) RN - EC 2.5.1.- (geranylgeranyltransferase type-I) RN - EC 2.5.1.21 (Farnesyl-Diphosphate Farnesyltransferase) RN - N21T0D88LX (geranylgeranyl pyrophosphate) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Alkyl and Aryl Transferases/*chemistry/metabolism MH - Brain/enzymology/metabolism MH - *Brain Chemistry MH - Chromatography, High Pressure Liquid/*methods MH - Farnesyl-Diphosphate Farnesyltransferase/*chemistry/metabolism MH - Female MH - Humans MH - Kinetics MH - Male MH - Middle Aged MH - Polyisoprenyl Phosphates/*analysis/metabolism MH - Sesquiterpenes/*analysis/metabolism MH - Tandem Mass Spectrometry/*methods EDAT- 2010/08/24 06:00 MHDA- 2011/01/06 06:00 CRDT- 2010/08/24 06:00 PHST- 2010/07/08 00:00 [received] PHST- 2010/08/02 00:00 [accepted] PHST- 2010/07/30 00:00 [revised] PHST- 2010/08/24 06:00 [entrez] PHST- 2010/08/24 06:00 [pubmed] PHST- 2011/01/06 06:00 [medline] AID - 10.1007/s00216-010-4088-7 [doi] PST - ppublish SO - Anal Bioanal Chem. 2010 Oct;398(4):1801-8. doi: 10.1007/s00216-010-4088-7. Epub 2010 Aug 21.